Maria J. Faus-Dader

Granada, AN 18071, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Primary health care policy and vision for community pharmacy and pharmacists in Spain.

Primary health care policy and vision for community pharmacy and pharmacists in Spain.

Journal: Pharmacy practice

Published: June 23, 2020

Impact of single nucleotide polymorphisms on the efficacy and toxicity of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients.

Impact of single nucleotide polymorphisms on the efficacy and toxicity of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients.

Journal: Mutation research. Reviews in mutation research

Published: November 22, 2017

Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer.

Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer.

Journal: Pharmacogenetics and genomics

Published: September 21, 2017

Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer.

Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer.

Journal: Pathology, research and practice

Published: September 05, 2017

Medication adherence and persistence in type 2 diabetes mellitus: perspectives of patients, physicians and pharmacists on the Spanish health care system.

Medication adherence and persistence in type 2 diabetes mellitus: perspectives of patients, physicians and pharmacists on the Spanish health care system.

Journal: Patient preference and adherence

Published: April 25, 2017

Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.

Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.

Journal: The pharmacogenomics journal

Published: March 13, 2017

Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer.

Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer.

Journal: Surgical oncology

Published: February 01, 2017

Liquid biopsy in early stage lung cancer.

Liquid biopsy in early stage lung cancer.

Journal: Translational lung cancer research

Published: November 09, 2016

Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer.

Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer.

Journal: Mutation research. Reviews in mutation research

Published: August 06, 2016

Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients.

Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients.

Journal: Pharmacological research

Published: June 02, 2016

Medication-related negative outcomes in patients with permanent atrial fibrillation attended in a hospital emergency department

Medication-related negative outcomes in patients with permanent atrial fibrillation attended in a hospital emergency department

Journal: Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias

Published: January 01, 2016

PTEN and PI3K/AKT in non-small-cell lung cancer.

PTEN and PI3K/AKT in non-small-cell lung cancer.

Journal: Pharmacogenomics

Published: November 12, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026